Evaluation of Photobiomodulation on Nasal Fractures
Nasal Fracture
About this trial
This is an interventional treatment trial for Nasal Fracture focused on measuring Nasal Fracture, Photobiomodulation, Laser, Edema
Eligibility Criteria
Inclusion Criteria:
- healthy participants.
- With a maximum of 48 hours after nasal trauma.
Exclusion Criteria:
- Patients using anticoagulant medication or use of medication that is anti-inflammatory chronically .
- Patients who report a hypersensitivity reaction to any drug used in the research
- Patients with previous nasal fractures.
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Active Comparator
Placebo Comparator
Experimental Group (laser)
Control group (Placebo)
The patients (n=18) will receive infrared LEDs in 6 points (3 on the right side and 3 on the left side) using a mask developed for the research . The irradiations will be performed with red LED ( wavelength = 660 nm) with output power of 100 milliwatt (mW) . The LED light outputs will be positioned in direct contact with the skin. During application of the LED both patient and operator will wear goggles. The red diode laser will be used. The power of the device is 100 mW and the wavelength used was 660nm (± 10nm). The diameter of the fiber optic of the apparatus has 600 μm, therefore a spot (area) of 0.002826cm2. The energy delivered per point is 1 Joule. 10 seconds of application is required. As 6 points are irradiated, the total energy delivered is 6 Joules. The energy density is 354 J / cm2 and the power density would be 35.4 W / cm2. The points will be determined by the same operator, obeying the protocol.
The patients (n=18) will receive the LED at the same points recommended for the experimental group, but will be off. So that the patient does not identify the sound of activation of the device (beep), it will be recorded, and connected at the time of the application of the laser. The questionnaire to assess the impact of treatment on quality of life will be applied at baseline and after 8 days (by the same evaluator), as well as the evaluation of serum CRP.